PE anti-human CD270 (HVEM, TR2) 318806 from BioLegend

Product Specs
ItemPE anti-human CD270 (HVEM, TR2)
CompanyBioLegend
Price Pricing Info Supplier Page View Company Product Page
Catalog Number318806
NCBI Gene AliasesATAR, CD270, HVEA, HVEM, LIGHTR, TR2
Quantity100 tests
ApplicationsFlow Cytometry (FC)
IsotypeIgG1, Kappa
Clone122
ReactivityHuman
HostMouse
Conjugate/TagPE
Antibody TypePrimary
NCBI Full Gene NameTNF receptor superfamily member 14
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ImmunogenRecombinant human HVEM protein
ClonalityMonoclonal
TargetCD270

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Lymphocyte HVEM/BTLA co-expression after critical illness demonstrates severity indiscriminate upregulation, impacting critical illness-induced immunosuppressionFrontiers in MedicineMay 25, 2023Michelle E. Wakeley, Brandon E. Armstead, Chyna C. Gray, Elizabeth W. Tindal, Daithi S. Heffernan, Chun-Shiang Chung, Alfred AyalaClone BW264/56 (Miltenyi Biotec, Cat# 130–113-133; CD3+ T-cells), PE-CD270, Clone 122 (BioLegend, Cat# 318806; HVEM+), and APC-CD272, Clone mih26 (BioLegend, Cat# 344510; BTLA+). Proliferation was assessed on fixed

(2) CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse modelJournal for ImmunoTherapy of CancerJanuary 27, 2022Ruikun Wang et al.BioLegend), MHC-Ⅱ (107614, BioLegend), programmed death-ligand 1 (PD-L1) (124312, BioLegend), and human HVEM (318805, BioLegend). For intracellular and nuclear staining, samples were fixed and permeabilized by the True-Nuclear

(3) Nectin-1 Expression Correlates with the Susceptibility of Malignant Melanoma to Oncolytic Herpes Simplex Virus In Vitro and In VivoCancersJune 19, 2021Schwertner B, Lindner G, Toledo Stauner C, Klapproth E, Magnus C, Rohrhofer A, Gross S, Schuler-Thurner B, Öttl V, Feichtgruber N, et al.

(4) Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulationNature communicationsFebruary 23, 2021Arenas EJ, Martínez-Sabadell A, Rius Ruiz I, Román Alonso M, Escorihuela M, Luque A, Fajardo CA, Gros A, Klein C, Arribas J.hCD80 (#305221), hCD86 (#305425), hGalectin-9 (#348905), hB7-H3 (#351003), hB7-H4 (#358103), hHVEM (#318805), hICOS-L (#309403), h41BB-L (#311503), hOX40-L (#316307), hIFNGR1 (#308606), hIFNGR2 (#308504), all

(5) Herpes Virus Entry Mediator (HVEM): A Novel Potential Mediator of Trauma-Induced ImmunosuppressionThe Journal of surgical researchJanuary 1, 2020Wakeley ME, Shubin NJ, Monaghan SF, Gray CC, Ayala A, Heffernan DS.Cat#555332; Beckman Coulter, APC Anti-Human CD3, PN#IM2467U), CD4 (Biolegend, PE-anti-human CD4, Cat# 318806) or CD8 (Biolegend, PE-anti-human CD8, Cat#344706) to identify lymphocytes, as well as for HVEM (Biolegend,

(6) LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial InfectionCell host & microbeAugust 8, 2018Seo GY, Shui JW, Takahashi D, Song C, Wang Q, Kim K, Mikulski Z, Chandra S, Giles DA, Zahner S, et al.561),BioLegend,Cat#343610; RRID: AB 2561358 Mouse monoclonal anti-human HVEM (clone 122),BioLegend,Cat#318805; RRID: AB 2203704 "Mouse IgG 1 kappa isotype control, PE",Thermo Fisher Scientific,Cat#12–4714-81;RRID:

(7) Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1Journal of immunological methodsMarch 1, 2016Jutz S, Leitner J, Schmetterer K, Doel-Perez I, Majdic O, Grabmeier-Pfistershammer K, Paster W, Huppa JB, Steinberger P.

(8) A stepwise protocol to coat aAPC beads prevents out-competition of anti-CD3 mAb and consequent experimental artefactsJournal of immunological methodsNovember 30, 2012Fuertes Marraco SA, Baumgaertner P, Legat A, Rufer N, Speiser DE.

(9) B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantationJournal of immunology (Baltimore, Md. : 1950)July 1, 2012Hobo W, Norde WJ, Schaap N, Fredrix H, Maas F, Schellens K, Falkenburg JH, Korman AJ, Olive D, van der Voort R, et al.

(10) Polymorphic variants of LIGHT (TNF superfamily-14) alter receptor avidity and bioavailabilityJournal of immunology (Baltimore, Md. : 1950)August 1, 2010Cheung TC, Coppieters K, Sanjo H, Oborne LM, Norris PS, Coddington A, Granger SW, Elewaut D, Ware CF.

(11) Ethanol and galactose metabolism as influenced by 4-methylpyrazole in alcoholics with and without nutritional deficiencies. Preliminary report of a new approach to pathogenesis and treatment in alcoholic liver diseaseAnnals of clinical researchAugust 1, 1975M P Salaspuro, K O Lindros, P Pikkarainen

Be the First to Write a Review!

PE anti-human CD270 (HVEM, TR2) from BioLegend

Description

BioLegend

Citations (11)

Reviews

PE anti-human CD270 (HVEM, TR2) from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map